has shown that high expression of MYEOV is significantly correlated with a low survival rate in patients with Pancreatic Ductal Adenocarcinoma (PDAC), with high expression of MYEOV promoting glycolysis in PDAC tumor cells. This evidence concerns the gene MYEOV and neoplasm.